State Of Wisconsin Investment Board Avrobio, Inc. Transaction History

State Of Wisconsin Investment Board

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$7.84 - $12.6 $344,960 - $554,400	-44,000 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$12.79 - $17.1 $70,345 - $94,050	-5,500 Reduced 11.11%	44,000 $613,000
Q3 2020 Nov 16, 2020	BUY	$12.99 - $19.41 $153,282 - $229,038	11,800 Added 31.3%	49,500 $644,000
Q2 2020 Aug 12, 2020	SELL	$12.19 - $22.96 $14,628 - $27,552	-1,200 Reduced 3.08%	37,700 $658,000
Q1 2020 May 06, 2020	BUY	$10.08 - $27.21 $154,224 - $416,313	15,300 Added 64.83%	38,900 $605,000
Q3 2019 Nov 12, 2019	BUY	$14.12 - $23.44 $72,012 - $119,544	5,100 Added 27.57%	23,600 $333,000
Q2 2019 Aug 14, 2019	BUY	$13.21 - $27.29 $244,385 - $504,865	18,500 New	18,500 $301,000
Q4 2018 Feb 11, 2019	SELL	$15.43 - $32.7 $97,209 - $206,010	-6,300 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$26.95 - $52.7 $169,785 - $332,010	6,300 New	6,300 $327,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.